Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center

NCT02922270 | Completed

• 1 other identifier: 252
• Study Type: observational
• Target: 277
• Locations: 0 countries
• Sites: N/A

Brief Summary

INTRODUCTION AND AIMS: The aims of this study were to evaluate patient and technique survival rates, investigate peritonitis rates and evaluate factors affecting mortality in peritoneal dialysis (PD) patients over a period of 20 years at Istanbul Faculty of Medicine Peritoneal Dialysis Unit. METHODS: Two hundred seventy seven patients have received PD as renal replacement therapy (RRT) over a period of 20 years. After exclusion of patients with follow-up shorter than 3 months and patients whose data were not available, 250 patients were examined retrospectively. Data for sex, age, primary disease, comorbidities, follow up duration, cause of death, and cause of technique failure were collected from medical records.

Conditions

Therapeutic Procedural Complication

Keywords

peritoneal dialysis: outcome; peritoneal dialysis: complications; peritoneal dialysis: technique; peritoneal dialysis: peritonitis

Outcome Measures

Primary Outcomes (1)

• Patient survival

  5 - 10 years

Secondary Outcomes (1)

• Treatment failure

  5 - 10 years

Study Arms (1)

Patients

Who have received PD as renal replacement therapy (RRT) over a period of 20 years.

Other: Peritoneal dialysis patients at the Istanbul Medical Faculty

Interventions

Peritoneal dialysis patients at the Istanbul Medical Faculty OTHER

The aims of this study were to evaluate patient and technique survival rates, investigate peritonitis rates and evaluate factors affecting mortality in peritoneal dialysis (PD) patients over a period of 20 years at Istanbul Faculty of Medicine Peritoneal Dialysis Unit.

Also known as: OUTCOME AND RISK FACTORS FOR MORTALITY

Patients

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Two hundred seventy seven patients have received PD as renal replacement therapy (RRT) over a period of 20 years.

You may qualify if:

• all patients 18 years of age and older
• treated with PD at the Istanbul Medical Faculty from October 1994 to October 2014

You may not qualify if:

• follow-up shorter than 3 months and patients whose data were not available,
• data were not available
• patients who were unwilling
• patients who unable to provide informed consent

Sponsors & Collaborators

• Istanbul University: lead

MeSH Terms

Interventions

Risk Factors; Mortality

Intervention Hierarchy (Ancestors)

Risk; Probability; Statistics as Topic; Epidemiologic Methods; Investigative Techniques; Causality; Epidemiologic Factors; Quality of Health Care; Health Care Quality, Access, and Evaluation; Health Care Evaluation Mechanisms; Public Health; Environment and Public Health; Vital Statistics; Data Collection; Demography; Population Characteristics; Epidemiologic Measurements

Study Officials

• Yasar Caliskan, Dr.

  Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director

Study Record Dates

• First Submitted: September 19, 2016
• First Posted: October 4, 2016
• Study Start: October 1, 1995
• Primary Completion: October 1, 2015
• Study Completion: October 1, 2015
• Last Updated: October 24, 2016

Record last verified: 2016-10

Data Sharing

• IPD Sharing: Will not share